Search Results - "Dauriz, M"

Mortality from infectious diseases in diabetes by Zoppini, G., Fedeli, U., Schievano, E., Dauriz, M., Targher, G., Bonora, E., Corti, M.C.

“…To investigate the risk of mortality from infections by comparing the underlying causes of death versus the multiple causes of death in known diabetic subjects…”
Get full text

Psychological distress, self-efficacy and glycemic control in type 2 diabetes by Indelicato, L, Dauriz, M, Santi, L, Bonora, F, Negri, C, Cacciatori, V, Targher, G, Trento, M, Bonora, E

“…Abstract Aim To investigate the association of glycemic control with depression, anxiety, self-efficacy and other diabetes-specific psychological measures in a…”
Get full text

Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population by De Santi, F, Zoppini, G, Locatelli, F, Finocchio, E, Cappa, V, Dauriz, M, Verlato, G

“…To estimate the prevalence of respiratory symptoms in individuals with type 2 diabetes, as compared to the general population. Between 2007 and 2010 the…”
Get full text

Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS by Moghetti, P., Catellani, C., Sartori, C., Migazzi, M., Cirillo, F., Villani, M., Buia, V., Righi, B., Dauriz, M., Fiers, T., Tosi, F., Street, M. E.

“…Purpose PCOS is associated with low grade inflammation which could play a role in insulin resistance and ovarian dysfunction. Preliminary findings suggested…”
Get full text

Effects of a psychological intervention on glycemic control and psychological distress in individuals with type 2 diabetes by Indelicato, L., Dauriz, M., Santi, L., Negri, C., Cacciatori, V., Bonora, E.

“…Aims: Increasing evidence suggests that psychological distress play an important role in the development and worsening of type 2 diabetes (T2D). Among the…”
Get full text

Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls by Zoppini, G., Bergamini, C., Trombetta, M., Sabbagh, L., Dauriz, M., Mantovani, A., Targher, G., Fossà, I., Rinaldi, E., Bonora, E.

“…Purpose Increased arterial stiffness is an early sign of endothelial dysfunction. Nevertheless, measures of the elastic properties of the aortic root in…”
Get full text

Assessment of simple strategies for identifying undiagnosed diabetes and prediabetes in the general population by Bonora, E., Dauriz, M., Rinaldi, E., Mantovani, A., Boscari, F., Mazzuccato, M., Vedovato, M., Gallo, A., Toffanin, E., Lapolla, A., Fadini, G. P., Avogaro, A.

“…Background and aims The rising tide of diabetes mellitus (DM) and prediabetes (PDM) is urgently calling for strategies easily applicable to anticipate…”
Get full text

Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications by Buzzetti, R, Prudente, S, Copetti, M, Dauriz, M, Zampetti, S, Garofolo, M, Penno, G, Trischitta, V

“…Abstract Aim We are currently facing several attempts aimed at marketing genetic data for predicting multifactorial diseases, among which diabetes mellitus is…”
Get full text

Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) by Dauriz, M., Bacchi, E., Boselli, L., Santi, L., Negri, C., Trombetta, M., Bonadonna, R.C., Bonora, E., Moghetti, P.

“…Lifestyle is considered a major determinant of risk of type 2 diabetes (T2D). We investigated whether daily physical activity (DPA) is associated with…”
Get full text

Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology by Buzzetti, R, Prudente, S, Copetti, M, Dauriz, M, Zampetti, S, Garofolo, M, Penno, G, Trischitta, V

“…We are currently facing several attempts aimed at marketing genetic data for predicting multifactorial diseases, among which diabetes mellitus is one of the…”
Get full text

Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low‐density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report by Zenti, M. G., Stefanutti, C., Sanga, V., Altomari, A., Fabris, A., Dauriz, M., Bonora, E.

“…A 49 years old woman (weight 68 kg, BMI 27.3 kg/m2) with heterozygous familial hypercholesterolemia (HeFH) and multiple statin intolerance with muscle aches…”
Get full text

Is common genetic variation at IRS1 , ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 by Trombetta, M, Dauriz, M, Bonetti, S, Travia, D, Boselli, L, Santi, L, Bonora, E, Bonadonna, R.C

“…Abstract Background and aims Insulin resistance is a hallmark of type 2 diabetes (T2DM), it is often accompanied by defective beta-cell function (BF) and is…”
Get full text

Usefulness of the Dutch lipid score to drive genetic testing in heterozygous familial hypercholesterolemia. The Verona experience in the lipigen study by Sanga, V, Altomari, A, Casula, M, Garlaschelli, K, Catapano, A.L, Ceradini, G, Bonora, E, Dauriz, M, Zenti, M.G

Get full text

Case report: Evolocumab in association with lipoprotein apheresis improves lipid profile in a 49-years old woman with familial hypercholesterolemia and statin intolerance by Zenti, M.G, Altomari, A, Sanga, V, Ceradini, G, Fabris, A, Lupo, A, Dauriz, M, Bonora, E

Get full text

Preliminary clinical experience of PCSK9 inhibitors in patients with heterozygous familial hypercholesterolemia. Considerations on their use in patients on lipoprotein apheresis treatment and in statins intolerant patients by Altomari, A, Sanga, V, Ceradini, G, Fabris, A, Lupo, A, Bonora, E, Dauriz, M, Zenti, M.G

Get full text

Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus by Zoppini, Giacomo, Trombetta, Maddalena, Sabbagh, Lara, Dauriz, Marco, Mantovani, Alessandro, Bergamini, Corinna

Get full text

Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report by Zenti, M G, Stefanutti, C, Sanga, V, Altomari, A, Fabris, A, Dauriz, M, Bonora, E

“…A 49 years old woman (weight 68 kg, BMI 27.3 kg/m2 ) with heterozygous familial hypercholesterolemia (HeFH) and multiple statin intolerance with muscle aches…”
Get full text